Contract awardedGP locally commissioned and enhanced services

Cora Health covers denosumab therapy for Basildon and Brentwood patients

NHS Essex Integrated Care Board hired Cora Health to keep denosumab therapy going for patients in Basildon and Brentwood. Primary care could not take the work on as soon as planned, so the board awarded it directly as an urgent measure.

Cora Health was to treat about 100 to 150 current patients over six weeks. It also had to complete shared care paperwork for about 700 patients not having injections then. That paperwork was to go to primary care in date order, ready for each patient's injection.

Prices were £53 for denosumab therapy and £20 for each patient record. The £20,000 contract ran from April 2026 and was due to end in June 2026.

What
GP locally commissioned and enhanced services
Supplier
Cora Health
Value
£20,000
How it was bought
Below threshold - without competition
Dates and next
Apr 2026 to Jun 2026

How it was bought

1 official notice
  1. 15 Apr 2026Contract starts
  2. 30 Jun 2026Contract ends
  3. 18 Aug 2026Award noticeFind a Tender

How it compares

With every GP locally commissioned and enhanced services award since 2021

Half of awards fall between £37,767 and £178,766Median £79,034

Awards
1,652
Firms that won them
1,392
Median award
£79,034
of 854 with a value
This award
Smaller than 84%
of them
Typical length
1 year
In East of England
18 awards

Cora Health ranks 840th of 1,392 firms for GP locally commissioned and enhanced services awards since 2021.

RankFirmAwardsValue
1Locked9£5m
2Locked8£436,738
3Locked7£17.1m
3Locked7£135,003
5Locked6£658,732
5Locked6·
840Cora Health Won this one1£20,000
See who wins this work

Figures to 21 November 2026

GP locally commissioned and enhanced services at other buyers

NHS Essex Integrated Care Board has awarded 86 contracts since 2021.

See NHS Essex Integrated Care Board's page
  • Cora Health has won 42 public contracts since 2021.